BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19237549)

  • 21. 2,3,7,8-tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3'alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line.
    Sulentic CE; Zhang W; Na YJ; Kaminski NE
    J Pharmacol Exp Ther; 2004 Apr; 309(1):71-8. PubMed ID: 14718603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCDD-mediated suppression of naïve human B cell IgM secretion involves aryl hydrocarbon receptor-mediated reduction in STAT3 serine 727 phosphorylation and is restored by interferon-γ.
    Blevins LK; Zhou J; Crawford R; Kaminski NE
    Cell Signal; 2020 Jan; 65():109447. PubMed ID: 31678681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Sulentic CE; Kaminski NE
    Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S171-91. PubMed ID: 20952503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
    Son DS; Rozman KK
    Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic TCDD exposure results in the dysregulation of gene expression in splenic B-lymphocytes and in the impairments in T-cell and B-cell differentiation in mouse model.
    Feng Y; Tian J; Krylova I; Xu T; Xie HQ; Guo TL; Zhao B
    J Environ Sci (China); 2016 Jan; 39():218-227. PubMed ID: 26899660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
    Snyder NK; Kramer CM; Dooley RK; Holsapple MP
    Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells.
    Boverhof DR; Tam E; Harney AS; Crawford RB; Kaminski NE; Zacharewski TR
    Mol Pharmacol; 2004 Dec; 66(6):1662-70. PubMed ID: 15371557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.
    Kovalova N; Manzan M; Crawford R; Kaminski N
    Toxicol Appl Pharmacol; 2016 Oct; 309():15-23. PubMed ID: 27535091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter analysis of TCDD-inducible genes in a thymic epithelial cell line indicates the potential for cell-specific transcription factor crosstalk in the AhR response.
    Frericks M; Burgoon LD; Zacharewski TR; Esser C
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):268-79. PubMed ID: 18691609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Phadnis-Moghe AS; Li J; Crawford RB; Kaminski NE
    Toxicol Appl Pharmacol; 2016 Nov; 310():41-50. PubMed ID: 27546522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation.
    Ohkubo Y; Arima M; Arguni E; Okada S; Yamashita K; Asari S; Obata S; Sakamoto A; Hatano M; O-Wang J; Ebara M; Saisho H; Tokuhisa T
    J Immunol; 2005 Jun; 174(12):7703-10. PubMed ID: 15944271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
    Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
    Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auto-induction mechanism of aryl hydrocarbon receptor 2 (AHR2) gene by TCDD-activated AHR1 and AHR2 in the red seabream (Pagrus major).
    Bak SM; Iida M; Soshilov AA; Denison MS; Iwata H; Kim EY
    Arch Toxicol; 2017 Jan; 91(1):301-312. PubMed ID: 27188387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.
    Lin KI; Angelin-Duclos C; Kuo TC; Calame K
    Mol Cell Biol; 2002 Jul; 22(13):4771-80. PubMed ID: 12052884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Karras JG; Holsapple MP
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
    Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aryl hydrocarbon receptor activation in genital tubercle, palate, and other embryonic tissues in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-responsive lacZ mice.
    Willey JJ; Stripp BR; Baggs RB; Gasiewicz TA
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):33-44. PubMed ID: 9705885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
    Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
    J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes.
    Masten SA; Shiverick KT
    Biochem Biophys Res Commun; 1995 Jul; 212(1):27-34. PubMed ID: 7541987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes.
    Schliephake DE; Schimpl A
    Eur J Immunol; 1996 Jan; 26(1):268-71. PubMed ID: 8566078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.